Latest Articles
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - Cure Today
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models Cure Today
Published: March 17, 2026, 5:11 p.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - CUREtoday.com
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models CUREtoday.com
Published: March 17, 2026, 4:12 p.m.
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors - Technology Networks
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors Technology Networks
Published: March 17, 2026, 4:04 p.m.
My Doctor Took One Look At My Watermelon-Sized Tumor And Said 6 Words. He Couldn’t Have Been More Wrong. - AOL.com
My Doctor Took One Look At My Watermelon-Sized Tumor And Said 6 Words. He Couldn’t Have Been More Wrong. AOL.com
Published: March 13, 2026, 1:48 a.m.
Olivia was troubled by mysterious symptoms: She thought she had a problem with fertility, she was diagnosed with a brain tumor! - lnginnorthernbc.ca
Olivia was troubled by mysterious symptoms: She thought she had a problem with fertility, she was diagnosed with a brain tumor! lnginnorthernbc.ca
Published: Feb. 16, 2026, 7:11 p.m.
MSK Endometrial Cancer e-Tumor Board - Medscape
MSK Endometrial Cancer e-Tumor Board Medscape
Published: Feb. 10, 2026, 11:06 p.m.
Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction - Quiver Quantitative
Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction Quiver Quantitative
Published: Jan. 29, 2026, 1:31 p.m.
APOs as promising prognostic biomarkers: correlation with tumor-infiltrating leukocytes in endometrial cancer - Frontiers
APOs as promising prognostic biomarkers: correlation with tumor-infiltrating leukocytes in endometrial cancer Frontiers
Published: Jan. 27, 2026, 10 p.m.
New cancer drugs show tumor shrinkage in early trials - Stock Titan
New cancer drugs show tumor shrinkage in early trials Stock Titan
Published: Jan. 8, 2026, 12:30 p.m.
Small-Cap Acrivon Showcases Tumor Reduction and Clinical Advancement in Major Trials, Shares Decline - Bitget
Small-Cap Acrivon Showcases Tumor Reduction and Clinical Advancement in Major Trials, Shares Decline Bitget
Published: Jan. 8, 2026, 3:12 a.m.
Link copied to clipboard!